ZFIN ID: ZDB-FISH-201111-4
Fish name: sirt1yu28/yu28(AB)
Genotype: sirt1yu28/yu28 (AB)
Targeting Reagent: none
HUMAN DISEASE MODELED by sirt1yu28/yu28(AB)
No data available
GENE EXPRESSION
Gene expression in sirt1yu28/yu28(AB)
RNA expression
Expressed Gene Structure Conditions Figures
casp3a standard conditions Fig. 3 with image from Kim et al., 2019
ifng1r standard conditions Fig. 3 with image from Kim et al., 2019
il1b standard conditions Fig. 3 with image from Kim et al., 2019
il6 standard conditions Fig. 3 with image from Kim et al., 2019
mmp2 standard conditions Fig. 3 with image from Kim et al., 2019
mmp9 standard conditions Fig. 3 with image from Kim et al., 2019
mpx standard conditions Fig. 5 with image from Kim et al., 2019
nfe2l2a standard conditions Fig. 3 with image from Kim et al., 2019
nos2a standard conditions Fig. 3 with image from Kim et al., 2019
ppargc1a standard conditions Fig. 3 with image from Kim et al., 2019
ptgs2a standard conditions Fig. 3 with image from Kim et al., 2019
rela standard conditions Fig. 5 with image from Kim et al., 2019
sirt1 standard conditions Fig. 1 with image,  Fig. 3 with image from Kim et al., 2019
socs1a standard conditions Fig. 3 with image from Kim et al., 2019
socs3a standard conditions Fig. 3 with image from Kim et al., 2019
sod1 standard conditions Fig. 3 with image from Kim et al., 2019
tgfb1a standard conditions Fig. 3 with image from Kim et al., 2019
tgfb2 standard conditions Fig. 3 with image from Kim et al., 2019
timp2a standard conditions Fig. 3 with image from Kim et al., 2019
tnfa standard conditions Fig. 3 with image,  Fig. 5 with image from Kim et al., 2019
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in sirt1yu28/yu28(AB)
Phenotype Conditions Figures
apoptotic process increased occurrence, abnormal control Fig. 2 with image from Kim et al., 2019
apoptotic process increased occurrence, exacerbated chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
apoptotic process occurrence, ameliorated chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
inflammatory response increased process quality, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
intestine atrophied, abnormal standard conditions Fig. 4 with image from Kim et al., 2019
intestine tnfa expression increased amount, abnormal standard conditions Fig. 5 with image from Kim et al., 2019
intestine rela expression increased amount, abnormal standard conditions Fig. 5 with image from Kim et al., 2019
intestine mpx expression increased amount, abnormal standard conditions Fig. 5 with image from Kim et al., 2019
intestine inflamed, abnormal standard conditions Fig. 4 with image from Kim et al., 2019
intestine apoptotic process increased occurrence, abnormal standard conditions Fig. 5 with image from Kim et al., 2019
intestine inflammatory response increased occurrence, abnormal standard conditions Fig. 4 with image,  Fig. 5 with image from Kim et al., 2019
pancreas inflamed, abnormal standard conditions Fig. 4 with image from Kim et al., 2019
pancreas inflammatory response increased occurrence, abnormal standard conditions Fig. 4 with image from Kim et al., 2019
reactive oxygen species biosynthetic process increased occurrence, abnormal control Fig. 2 with image from Kim et al., 2019
reactive oxygen species biosynthetic process increased occurrence, exacerbated chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
reactive oxygen species biosynthetic process occurrence, ameliorated chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
spleen inflamed, abnormal standard conditions Fig. 4 with image from Kim et al., 2019
spleen inflammatory response increased occurrence, abnormal standard conditions Fig. 4 with image from Kim et al., 2019
whole organism sirt1 expression absent, abnormal standard conditions Fig. 1 with image from Kim et al., 2019
whole organism decreased life span, abnormal standard conditions Fig. 5 with image from Kim et al., 2019
whole organism socs3a expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism il6 expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism socs1a expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism nfe2l2a expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism il1b expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism nos2a expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism casp3a expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism tnfa expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism tgfb1a expression increased amount, abnormal standard conditions Fig. 3 with image from Kim et al., 2019
whole organism viability, ameliorated chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019

CITATIONS  (1)

Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.